Macrolides in critically ill patients with Middle East Respiratory Syndrome
Open Access
- 25 January 2019
- journal article
- research article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 81, 184-190
- https://doi.org/10.1016/j.ijid.2019.01.041
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trialAntiviral Research, 2017
- Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?Journal of Allergy and Clinical Immunology, 2015
- Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective AnalysisPLOS ONE, 2013
- Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumoniaIntensive Care Medicine, 2013
- Macrolide Antibiotics and Survival in Patients With Acute Lung InjurySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory MedicationsClinical Microbiology Reviews, 2010
- A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitiorVirology Journal, 2010
- [Cytokine storm in avian influenza].2008
- Erythromycin Inhibits Rhinovirus Infection in Cultured Human Tracheal Epithelial CellsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infectionEuropean Respiratory Journal, 1999